Aldeyra Stock Filter Stocks by Fundamentals
ALDX Stock | USD 3.27 0.19 6.17% |
Aldeyra fundamentals help investors to digest information that contributes to Aldeyra's financial success or failures. It also enables traders to predict the movement of Aldeyra Stock. The fundamental analysis module provides a way to measure Aldeyra's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aldeyra stock.
Aldeyra | Price to Earning |
Aldeyra Price to Earning Analysis
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 15.9M | 16.1M | 15.7M | 8.0M | Total Assets | 233.1M | 181.3M | 148.3M | 78.6M |
Aldeyra Price to Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Aldeyra is extremely important. It helps to project a fair market value of Aldeyra Stock properly, considering its historical fundamentals such as Price to Earning. Since Aldeyra's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aldeyra's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aldeyra's interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
Aldeyra Retained Earnings
Based on the latest financial disclosure, the price to earning indicator of Aldeyra is roughly 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Price to Earning (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Aldeyra Fundamentals
Return On Equity | -0.28 | ||||
Return On Asset | -0.16 | ||||
Current Valuation | 45.1 M | ||||
Shares Outstanding | 58.9 M | ||||
Shares Owned By Insiders | 2.01 % | ||||
Shares Owned By Institutions | 60.64 % | ||||
Number Of Shares Shorted | 1.83 M | ||||
Price To Earning | (4.44) X | ||||
Price To Book | 1.44 X | ||||
EBITDA | (42.53 M) | ||||
Net Income | (37.54 M) | ||||
Cash And Equivalents | 163.83 M | ||||
Cash Per Share | 2.80 X | ||||
Total Debt | 15.66 M | ||||
Debt To Equity | 0.1 % | ||||
Current Ratio | 7.83 X | ||||
Book Value Per Share | 2.02 X | ||||
Cash Flow From Operations | (30.33 M) | ||||
Short Ratio | 4.55 X | ||||
Earnings Per Share | (0.64) X | ||||
Target Price | 9.0 | ||||
Number Of Employees | 10 | ||||
Beta | 1.52 | ||||
Market Capitalization | 180.81 M | ||||
Total Asset | 148.33 M | ||||
Retained Earnings | (394.26 M) | ||||
Working Capital | 125.55 M | ||||
Current Asset | 28.09 M | ||||
Current Liabilities | 2.12 M | ||||
Z Score | 3.28 | ||||
Net Asset | 148.33 M |
About Aldeyra Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aldeyra's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aldeyra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aldeyra based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts. Aldeyra Therapeu operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aldeyra in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aldeyra's short interest history, or implied volatility extrapolated from Aldeyra options trading.
Pair Trading with Aldeyra
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aldeyra position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will appreciate offsetting losses from the drop in the long position's value.Moving against Aldeyra Stock
0.52 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
The ability to find closely correlated positions to Aldeyra could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aldeyra when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aldeyra - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aldeyra to buy it.
The correlation of Aldeyra is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aldeyra moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aldeyra moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aldeyra can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aldeyra Piotroski F Score and Aldeyra Altman Z Score analysis. For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.Note that the Aldeyra information on this page should be used as a complementary analysis to other Aldeyra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Aldeyra Stock analysis
When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Aldeyra's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aldeyra. If investors know Aldeyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aldeyra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Return On Assets (0.16) | Return On Equity (0.28) |
The market value of Aldeyra is measured differently than its book value, which is the value of Aldeyra that is recorded on the company's balance sheet. Investors also form their own opinion of Aldeyra's value that differs from its market value or its book value, called intrinsic value, which is Aldeyra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aldeyra's market value can be influenced by many factors that don't directly affect Aldeyra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aldeyra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aldeyra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aldeyra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.